Severe hypoxia exerts parallel and cell-specific regulation of gene expression and alternative splicing in human mesenchymal stem cells by unknown
Hu et al. BMC Genomics 2014, 15:303
http://www.biomedcentral.com/1471-2164/15/303RESEARCH ARTICLE Open AccessSevere hypoxia exerts parallel and cell-specific
regulation of gene expression and alternative
splicing in human mesenchymal stem cells
Xinyang Hu1†, Rongrong Wu1†, Lina A Shehadeh2,3,4†, Qing Zhou6, Cizhong Jiang6, Xin Huang1, Ling Zhang1,
Feng Gao1, Xianbao Liu1, Hong Yu1,4, Keith A Webster3,4,5* and Jian’an Wang1*Abstract
Background: The endosteum of the bone marrow provides a specialized hypoxic niche that may serve to preserve
the integrity, pluripotency, longevity and stemness of resident mesenchymal stem cells (MSCs). To explore the
molecular genetic consequences of such a niche we subjected human (h) MSCs to a pO2 of 4 mmHg and analyzed
global gene expression and alternative splicing (AS) by genome-exon microarray and RT-qPCR, and phenotype by
western blot and immunostaining.
Results: Out of 446 genes differentially regulated by >2.5-fold, down-regulated genes outnumbered up-regulated
genes by 243:203. Exon analyses revealed 60 hypoxia-regulated AS events with splice indices (SI) >1.0 from 53 genes
and a correlation between high SI and degree of transcript regulation. Parallel analyses of a publicly available AS study
on human umbilical vein endothelial cells (HUVECs) showed that there was a strong cell-specific component with only
11 genes commonly regulated in hMSCs and HUVECs and 17 common differentially spliced genes. Only 3 genes were
differentially responsive to hypoxia at the gene (>2.0) and AS levels in both cell types. Functional assignments revealed
unique profiles of gene expression with complex regulation of differentiation, extracellular matrix, intermediate filament
and metabolic marker genes. Antioxidant genes, striated muscle genes and insulin/IGF-1 signaling intermediates were
down-regulated. There was a coordinate induction of 9 out of 12 acidic keratins that along with other epithelial and
cell adhesion markers implies a partial mesenchymal to epithelial transition.
Conclusions: We conclude that severe hypoxia confers a quiescent phenotype in hMSCs that is reflected by both the
transcriptome profile and gene-specific changes of splicosome actions. The results reveal that severe hypoxia imposes
markedly different patterns of gene regulation of MSCs compared with more moderate hypoxia. This is the first study
to report hypoxia-regulation of AS in stem/progenitor cells and the first molecular genetic characterization of MSC in a
hypoxia-induced quiescent immobile state.
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The stem cell niche refers to a well-defined physiological
compartment that includes cellular and acellular compo-
nents and serves to integrate systemic and local signals
to regulate the biology of stem cells (reviewed in [1,2]).
Like other such niches, the bone marrow provides highly
specialized and heterogeneous microenvironments that
determine the self-renewal, multipotency, survival and
migration of residing hematopoietic and progenitor cells
including mesenchymal stem cells (MSCs). Recently oxy-
gen tension (hypoxia) has been recognized as an import-
ant component of stem cell niches that exerts control
over the proliferation, differentiation and pluripotency of
resident cells [3-5]. The oxygen tension of the endos-
teum, a narrow compartment of the bone marrow dir-
ectly adjacent to the bone, is less than 10 mmHg, while
that of the sinusoidal cavity ranges between 30–
60 mmHg; therefore bone marrow cells are subject to a
gradient of hypoxia the severity of which depends on
their location within the niche [3,6]. Studies of embry-
onic stem cells (ESCs) as well as induced pluripotential
stem cells (iPSC) indicate that oxygen gradients control
stem cell functions. Culture of ESCs under an aerobic
pO2 of 160 mmHg causes spontaneous differentiation
that is suppressed by more physiological pO2 within the
range of 14–36 mmHg. Further reduction of pO2 to
<10 mmHg, equivalent to the bone marrow endosteum
suppresses both differentiation and proliferation of ESCs
while retaining pluripotency [7,8]. Studies on bone mar-
row or adipose derived MSCs have shown similarly that
moderate hypoxic culture equivalent to the central BM
sinusoidal niche enhances proliferation and protects
against senescence while more severe hypoxia may block
proliferation and induce cell death [9-16].
Culture of MSCs under moderate hypoxia has been
shown to modulate gene expression by HIF-1/2-dependent
and independent mechanisms [8,17-21]. In addition to the
predicted HIF-1α target genes such as those required for
anaerobic metabolism (glycolytic enzymes, glucose trans-
porters), cell cycle (p21, p53), and angiogenesis (VEGF),
moderate hypoxia was shown to mediate increased expres-
sion of Oct4 and telomerase activity of human bone mar-
row MSCs [16,22,23]. When cultured under moderate
hypoxia (20–40 mmHg O2), MSCs display enhanced
proliferation and migratory activity that has been at-
tributed to increased Akt phosphorylation, expression
of c-MET, VEGF, chemokine receptors CXCR4 and
CXCR1, and increased phosphorylation of focal adhe-
sion kinase [10,18,19,24-26]. Suppression of stem cell
differentiation by hypoxia has been linked to Notch
pathway signaling wherein hypoxia promotes recruit-
ment of HIF-1α to the Notch intracellular domain and
subsequently to Notch-dependent promoters thereby
enhancing their expression [27]. Recently, HIF-1α wasshown to regulate MSC proliferation through the en-
hancement of TWIST expression, which down-regulates
the E2A-p21 pathway, inhibits senescence and increases
proliferation [28]. Oxygen tensions between 20 and
40 mmHg enhance proliferation and pluripotency of
stem cells whereas tension below 10 mmHg (<1%) inhibit
proliferation and may promote apoptosis [8-12,17-19].
Up to 95% of all human genes are alternatively
spliced [29,30]. AS results in changes in composition of
an mRNA produced from a given gene, brought about
by changes in splice site choice and thence the produc-
tion of proteins with different properties. AS is regu-
lated by cell specific, developmental, and extracellular
signal-regulated cues and pathways (Reviewed in [31]).
Aberrant alternative splicing can cause disease and may
contribute to cancer and neurodegenerative disease
[32,33]. Exon arrays allow for detection and quantifica-
tion of AS on a genome-wide scale. There are currently
only 2 such reports of genome-wide analyses of hypoxia-
related changes in pre-mRNA splicing. One identified
Lama3 as a hypoxia-related splice variant in head and neck
cancers [34]. Another analyzed the effects of hypoxia on
AS in human umbilical vein endothelial cells (HUVECs)
and identified multiple alternative splice events [35].
Here we investigated the effects of severe hypoxia on
gene expression, exon splicing, and phenotype of human
(h) MSCs. The results reveal for the first time unique
sets of (severe) hypoxia-activated and repressed genes,
many of which differ from those reported previously
for more moderate hypoxia. We report for the first
time a coordinate increase in expression of acidic kera-
tins perhaps indicating a partial mesenchymal to epithelial
(epidermal) transition (MET), a decrease in insulin/IGF-1
signaling with lower phosphor-Akt, and decreased expres-
sion of anti-oxidant-related genes that suggests lower me-
tabolism and growth compared with aerobic culture. The
expression of differentiation-related markers is consistent
with enhancement of osteogenic and angiogenic pathways
perhaps at the expense of myogenesis and adipogenesis.
We also identify a novel set of hypoxia-regulated alterna-
tively spliced transcripts in hMSCs. To our knowledge this
is the first study to report on patterns of hypoxia-
mediated alternative splicing in stem cells. The results
provide a molecular framework for understanding the role
of severe hypoxia in preserving bone marrow progenitor
cell integrity and perhaps insights into the role of hypoxia
in regulating cell biology in hypoxic niche environments
such as the endosteum.
Results
Isolation and characterization of human MSCs
Human bone marrow MSCs were isolated as described
in Methods and used at passage 8. At this time cells
were visually homogeneous, fibroblast-like and positive
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(99.0%) and CD166 (41.8%) and negative for the expres-
sion of hematopoietic lineage marker CD34 (0.4%). These
characteristics were unaltered after exposure to hypoxia
for 24 h (Figure 1A and 1B).
Gene expression array
Gene expression profiles comparing normoxia and hyp-
oxia were obtained using Agilent Human 4 × 180 K Exon
and 8 × 60 K-GE microarrays as described in Methods.
Only the Exon arrays are described in the present ana-
lysis and the GE arrays were used for confirmation of
some gene transcripts. Hierarchical clustering of the Exon
arrays confirmed high reproducibility between samples
(Additional file 1: Figure S1). A robust response to hyp-
oxia was confirmed by quantifying HIF-1α-regulated tran-
scripts. As shown in Table 1, multiple well-characterized
HIF-1α-regulated genes were represented including car-
bonic anhydrase (>5-fold), metallothionein (>4-fold) and
VEGF-A (>4-fold). Most of these genes have been re-
ported previously in similar high throughput analyses of
MSCs exposed to hypoxia in the range 1-5% [14,17-19].
Noteworthy in our analyses are the strong inductions of
leptin and insulin-like growth factor binding protein 1
transcripts, confirmed in both Exon and K-GE arrays
(latter data not shown) and relatively low induction of
Bnip3 and glucose transporters. Glycolytic enzymeFigure 1 Characterization of hMSCs cultures under air or hypoxia. (A)
and hypoxic hMSCs (H-MSC). Conditions and procedures are described in Mgenes are widely recognized as markers of hypoxia with
at least 8 of 11 glycolytic enzymes genes responsive
through the HIF-1α pathway (reviewed in [36]). Sur-
prisingly, glycolytic gene transcripts were not repre-
sented in the 2.5-fold cut-off groupings used for our
array analyses, therefore we used RT-PCR to quantify
phosphofructokinase (PFK) a major rate-limiting en-
zyme [37], phosphoglycerate kinase (PGK) a strong hyp-
oxia responder [38], phosphoglycerate mutase (PGAM), a
moderate responder [39] and glyceraldehyde-3-phosphate
dehydrogenase (GAPDH), that is regulated by hypoxia in
a tissue-specific manner [40-42]. As indicated in the Table,
transcript levels of PFK and PGK increased, there was no
significant change of GAPDH (p = 0.20, n = 7) and PGAM
transcripts decreased (p = 0.02, n = 7). The results suggest
mixed responses of individual genes. Glycolytic flux in-
creased significantly under hypoxia; aerobic cultures used
glucose at a rate of 2.83 ± 0.2 mg/dL/h compared with
3.33 ± 0.1 mg/dL/h for hypoxia (p > 0.05; n = 3), and there
was a parallel increased rate of lactic acid generation over
24 h (data not show). Glycolytic flux is largely regulated
by small molecule binding and allosteric control of PFK,
the main rate-limiting enzyme and most of the pathway
enzymes are present in large excess. Induction of gene ex-
pression by hypoxia is likely to be a chronic adaptation
that is not required for the acute response to substrates
and energy level.Morphology and (B) surface antigen profiling of normoxic (N-MSC)
ethods. Representative of n = 3.
Figure 2 Real-time PCR (RTqPCR) validation of differentially
expressed genes. RTqPCR was implemented on the same mRNA
samples used for microarray as described in Methods. Results are
mean ± SEM of n = 3.
Table 1 HIF-1 regulated transcripts
Gene description Gene symbol Fold change HX/NX
Leptin LEP 74.3
Insulin-like growth factor binding protein 1 IGFBP1 8.93
Phopshoglycerate kinase PGK 7.10*
Lysyl oxidase-like 4 LOXL4 6.5
Carbonic anhydrase IX CA9 5.55
Metallothionein 3 MT3 4.78
Vascular Endothelial Growth Factor A VEGFA 4.61
Carbonic anhydrase XII CA12 4.62
Lysyl Oxidase LOX 3.99
Basic helix-loop-helix family member 40 BHLHE40 3.97
Adrenomedullin ADM 3.39
Placental Growth Factor PGF 3.28
Phosphofructokinase PFK 3.20*
Insulin-like growth factor binding protein 3 IGFBP3 3.10
Angiopoietin-like 4 ANGPTL4 2.88
BCL2/adenovirus E1B 19 kDa interacting protein 3 Bnip3 2.17
Lactate Dehydrogenase-A LDH-A 2.10
Glyceraldehyde-3-Phosphate Dehydrogenase GAPDH 1.48*
PhopshoGlycerate Mutase PGAM 0.70*
Solute carrier family 2 (facilitated glucose transporter), member 1 SLC2A1 (GLUT 1) 2.01
Solute carrier family 2 (facilitated glucose transporter), member 3 SLC2A1 (GLUT 3) 2.11
Genes were identified from the gene expression array and all values are significant (p < 0.05, n = 3). For genes with (*), transcripts were quantified by QPCR using
3 different preparations of hMSCs run in duplicate; (PGK p < 0.001; PFK, p < 0.01; GAPDH, p = 0.21; PGAM, p = 0.02; all n = 7).
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change (p < 0.05). In agreement with previous reports on
the effects of hypoxia on human MSC and endothelial
cells [17-19,35] we found that more genes were down-
than up-regulated (243 vs. 203). In order to confirm the
microarray results RT-PCR was implemented on 3
known HIF-1α target genes in addition to the glycolytic
transcripts described above, and four hypoxia-induced
genes not previously identified as HIF targets. As shown
in Figure 2, leptin (LEP), metallothionein-3 (MET3)
and lysyl oxidase (LOX) were all confirmed to increase
in a manner that reflected the array data. Similarly tran-
scripts of non-HIF-regulated genes, keratin-16 (KRT16),
Serpin peptidase inhibitor-1 (PAI-1), RAS p21 protein
activator (RASA1) and Immediate Early Response 3
(IER3) were also confirmed to increase in the hypoxic
samples in a manner that reflected the array data. West-
ern blot and ELISA further confirmed that the levels of
secreted hypoxia-marker genes VEGF and leptin were
significantly increased by hypoxia in the spent media
(Figure 3A and B). Figure 4 and Tables 2 and 3 show
some of the most strongly hypoxia-regulated genes sepa-
rated into functional categories. GO analyses identified 3
categories including [1] antioxidant pathways, NAD(P)H
quinone-1, aldo-keto reductase family members andthioredoxin reductase were markedly down-regulated [2]
extracellular matrix structural constituents in particular
collagens were subject to up and down regulation sug-
gesting dynamic changes of the ECM and [6] glucose
transporters that were also subject to both up and
down-regulation (see Figure 4 and Tables 2 and 3).
Figure 3 Quantification of leptin and VEGF protein in MSC spent media during exposure to hypoxia. (A) Numbers in left panel refer to
time (h) under hypoxia. (B) VEGF incubation time was 24 h. All results are representative of 3 separate experiments; *p < 0.05, n = 3.
Figure 4 Heatmaps of differentially expressed genes in 2 main Gene Ontology (GO) molecular functions. Differentially expressed genes in
human MSCs under hypoxia were subjected to GO analysis. A significance cut-off of p < 0.05 was used.
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Table 2 Up-regulated genes and functional group
allocations






Early Growth Response 2 EGR2 6.78
Inhibin, beta B INHBB 6.25
Interleukin 11 IL11 5.5
Growth differentiation factor 6 GDF6 5.29
Hemopoietic cell kinase HCK 4.82
Podoplanin PDPN 3.65
Ephrin-A3 EFNA3 3.65
Semaphorin A7 SEMA7 2.70
Activin A receptor type IIA ACVR2A 2.70
Matrix metalloproteinase 11 MMP11 2.52
Aggrecan ACAN 2.50
Sparc/osteonectin (testican) SPOCK1 2.2
Frizzled homologue-8 FZD8 3.2
Secreted frizzled related protein 4 SFRP4 2.3
Cadherin 11, type 2 (osteoblast) CDH11 2.0
Survival/Apoptosis
Transient receptor potential cation
channel
TRPM7 6.63
Interleukin 11 IL11 5.5
Metallothionein 3 MT3 4.80
Stanniocalcin 1 STC1 4.8
Regucalcin RGN 4.04
Vascular endothelial growth factor A VEGFA 3.56
RAS p21 protein activator 1 RASA1 2.92
Immediate Early Response 3 IER3 2.52
Proliferation/Survival
Insulin-like growth factor binding protein 1 IGFBP1 8.93
Insulin-like growth factor binding protein 3 IGFBP3 3.1
Insulin-like growth factor binding protein 5 IGFBP5 3.1
Interleukin 11 IL11 5.5
Placental Growth Factor PGF 3.28
Transcription elongation factor A3 TCEA3 2.82
Hepatocyte growth factor receptor MET 2.70
Heparin-binding EGF-like GF HBEGF 2.64
Jun B oncogene JUNB 3.07
c-Jun oncogene JUN 2.66
Inhibin, beta B INHBB 6.25
Growth differentiation factor 6 GDF6 5.29
Inhibitor of growth family member 3 ING3 3.53
ECM migration/adhesion/cytoskeleton
Early growth response 2 EGR2 6.78
Table 2 Up-regulated genes and functional group
allocations (Continued)
Interleukin 11 IL11 5.5
Activated leukocyte cell adhesion
molecule
ALCAM 2.89
Junctional adhesion molecule 2 JAM2 3.10
Semaphorin 5A SEMA5A 4.02
Connective tissue growth factor CTGF 2.40






Intergrins alpha- 1, 3, 5, 6, 7 ITGA >2.2




Keratin 16 KRT16 6.39
Keratin 14 KRT14 4.04
Keratin 20 KRT20 4.40
Keratin 19 KRT19 3.5
Keratin 15 KRT15 3.35
Keratin 13 KRT13 3.37
Keratin 24 KRT24 3.09
Keratin 17 KRT17 2.70
Keratin 12 KRT12 2.60
Mucin 1 MUC1 2.23
KIAA1199 KIAA1199 5.2
RAS p21 protein activator RASA1 2.92
Microtubule-associated protein 1B MAO1B 2.70
Microtubule-actin cross-linking factor 1 MACF1 2.4
Lysyl oxidase-like 4 LOX4 6.5
Lysyl oxidase-like 2 LOX2 2.5
Angiogenesis
Leptin LEP 74.3
Stanniocalcin 1 STC1 4.70
Vascular endothelial growth factor A VEGFA 4.61
Placental growth factor PGF 3.28
Hepatocyte growth factor receptor MET 2.70
PDGF receptor B PDGFRB 2.1
PDGF receptor A PDGFRA 2.0
Angiopoietin-like 4 ANGPTL4 2.80
Serpin peptidase inhibitor member 1 SERPINE1 4.92
Serpin peptidase inhibitor member 2 SERPINE2 2.4
Tissue plasminogen activator PLAT 2.3
Endothelial tyrosine kinase, Ang 1
receptor
TEK 5.16
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Table 2 Up-regulated genes and functional group
allocations (Continued)




Glucose transporter member 1 SLC2A1 2.01
Glucose transporter member 3 SLC2A3 2.11
Glucose/fructose transporter member 5 SLC2A5 2.0
Glucose transporter, member 14 SLC2A14 2.88
Genes were identified from the gene expression array using Genespring
software and GO analysis to assign functional categories as described in
Methods and manually from inspection of the arrays. All values are significant
(p < 0.05, n = 3).
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Intermediate filaments and microfilaments provide scaf-
folding that allows cells to rapidly remodel in response
to environmental or intracellular signals, for example to
increase or decrease movement and/or cell adhesion
[43,44]. Intermediate filaments and their keratin struc-
tural components are markers of epithelium where in
combination with cell junction components, desmo-
somes, hemidesmosomes and integrins, they contribute
to the adhesion of epithelial cells to the basement mem-
brane [43]. The keratins that compromise intermediate
filaments are typically selected from 12 acidic (type 1)
and 8 basic (type 2) cytokeratins that usually dimerize
with specific partners from the opposite group to form
organized filaments. Acidic keratins are coded on
chromosome 17q whereas the basic keratins are clus-
tered on chromosome 12q. The gene expression analysis
revealed a remarkable increase in the expression of 9 out
of 12 acidic keratins and decreased transcript levels of 3
(K2, K4, K5) out of 8 basic keratins with no change of
the other members (Tables 2 and 3). To determine
whether these changes in gene expression were reflected
at the protein and cell structural levels, we measured
K16 protein by western blot and the organization of
intermediate and microfilaments respectively by keratin
and F-actin immunostaining. As shown in Figure 5,
K16 levels were increased by 2 ± 0.1-fold (p < 0.05) in
MSC after exposure to hypoxia and this was associated
with a change in the organization of intermediate fila-
ments and altered cellular morphology (Figure 5B). The
changes in cell shape and organization of cytoplasmic
filaments indicated by keratin staining were also
reflected by similar cell images imaged by F-actin im-
munostaining (Figure 5C). Other proteins related to inter-
mediate filaments structure and function that were also
increased by hypoxia include periplakin and desmoplakin,junctional adhesion molecule 2 (JAM2), adipocyte-specific
adhesion molecule (ASAM) adhesion molecule with Ig-
like domain 2 (AMIGO2) and podoplanin (PDPN) (see
Table 2). In addition, six integrins (α-1,-3,-5,-6,-7, β-1)
were increased by >2-fold. These changes may reflect a
partial mesenchymal to epithelial transition (MET) that is
a reversal of epithelial to mesenchymal transition (EMT) a
well-established pathway associated with development
and carcinogenesis. MET is predicted to involve reduced
cell mobility and proliferative quiescence [45]. Interest-
ingly hypoxia also increased the transcript levels of the
HGF receptor c-MET that is normally expressed by cells
of epithelial origin (Table 2).Regulation of differentiation
MSCs are pluripotent with the capacity to differentiate
into adipocytes, osteocytes, chondrocytes, endothelium,
neurons and muscle as well as hematopoietic cells. It
has been reported that moderate hypoxia >10 mmHg in-
creased [19,46] or decreased [23,47,48] adipogenic differen-
tiation and increased [10,19,47,48] or decreased [20,23]
osteogenic differentiation of MSCs. In our studies, com-
bined GO and manual analyses revealed trends of hypoxia-
regulated differentiation markers that suggest repression of
adipogenesis and myogenesis in favor of osteogenesis,
angiogenesis and hematopoiesis. Leptin, interleukin-11
(Il-11), growth differentiation factor-6 (GDF6), and MMP11,
all strongly induced by hypoxia, are secreted factors
that favor osteogenesis over adipogenesis [49-51]. Colla-
gens are major constituents of the bone matrix and are
highly expressed in MSCs. Type 1 collagen, the main
osteogenic collagen was not amongst the regulated genes,
however, multiple other osteogenic markers genes includ-
ing aggrecan (ACAN), sparc/osteonectin (SPOCK1), osteo-
blast cadherin (CDH11) and Wnt pathway members
Frizzled homologue-8 (FZD8) and Secreted frizzled related
protein 4 (SFRP4) were induced in parallel with decreased
expression of the negative osteogenic regulator osteocrin
(Tables 2 and 3) [52,53]. Four of the most strongly induced
genes including early growth response 2 (EGR2 > 6-fold)
[54], interleukin 11 (Il-11 > 5-fold), growth differentiation
factor 6 (GDF6 > 5-fold) and hemopoietic cell kinase (HCK
~5-fold) as well as activin-A receptor (2-fold [55]) are asso-
ciated with hematopoiesis. Transcript levels of multiple
genes associated with angiogenesis were increased by hyp-
oxia [56] while there were marked decreases of multiple
striated muscle markers (Tables 2 and 3). The coordinate
decrease of 3 Inhibitor of DNA binding factors ID1,
ID2, and ID4 (Table 3) is also consistent with a switch
in differentiation patterns. Taken together the results sup-
port inductions of multiple marker genes for osteogenesis,
angiogenesis, and hematopoiesis by severe hypoxia that
may predispose cells to these lineages.
Table 3 Down-regulated genes and functional group
allocations





NAD(P)H dehydrogenase, Quinone 1 NQO1 −5.63
Aldo-Keto Reductase 1C1 AKR1C1 −2.71
Aldo-Keto Reductase 1C2 AKR1C2 −2.61
Aldo-Keto Reductase 1C3 AKR1C3 −2.60
Aldo-Keto Reductase 1C4 AKR1C4 −4.28
Aldo-Keto Reductase1D1 AKR1D1 −3.04
Aldo-Keto Reductase 1B10 AKR1B10 −3.07
Aldo-Keto Reductase 1B15 AKR1B15 −2.10
Glucose 6 phosphate DH G6PDH −2.00
Thioredoxin reductase TXNRD1 −3.77
Proliferation/growth associated
Insulin-like growth factor 1 IGF-1 −3.2
PI3-kinase regulatory subunit 2 PIK3R2 −2.9
Platelet derived growth factor receptor-like PDGFRL −2.85
Fibroblast growth factor 7 FGF7 −2.1
Cell cycle arrest checkpoint RAD9B −4.4
Mediator of DNA damage checkpoint 1 MDC1 −3.39
Helicase (DNA) B HELB −4.4
Inhibitor of DNA binding 1 ID1 −3.26
Inhibitor of DNA binding 2 ID2 −3.0
Inhibitor of DNA binding 4 ID4 −3.0
TNF superfamily, member 14 TNFSF14 −2.22
Migration-associated
Phosphatidylinositol-3,4,5-trisphosphate-
dependent Rac exchange factor 1
PREX1 −2.23
Coronin 7 CORO7 −5.10
Formin homology 2 domain containing 1 FHOD1 −2.15
Actin filament associated protein 1 like 2 AFPAP1L2 −3.3
Palmdelphin PALMD −2.8
Tubulin, alpha 3D TUBA3D −3.9
Glucose metabolism
Glucose 6 phosphate DH G6PDH −2.00
Pyruvate dehydrogenase (liver RBC) PKLR −2.61
Phosphoglycerate mutase 2 PGAM2 −3.00
Phosphoglycerate mutase 5 PGAM5 −2.27
Phosphogluconate dehydrogenase PGD −2.55
Glucose transporter, member 4 SLC2A4 −2.7
Glucose transporter, member 8 SLC2A8 −2.5
Glucose/fructose transporter, member 11 SLC2A11 −2.24
Muscle/myogenesis/structural
Actin alpha-1 (Sk) ACTA1 −4.33
Actin gamma-2 (SM) ACTG2 −5.83
Table 3 Down-regulated genes and functional group
allocations (Continued)
Fer-1-like 5 (myotube formation) FER1L5 −5.30
Tripartite motif containing 16-like TRIM16L −4.95
Myosin heavy chain 2 MYH2 −4.0
Myosin heavy chain 7 MYH7 −3.0
Troponin T type 2 (cardiac) TNNT2 −2.8
ATPase calcium channel (cardiac) ATP2A1 −2.94
Myosin binding protein B (fast) MYBPC2 −2.79
Miscellaneous
Lysine acetyl transferase 2A KAT2A −3.45
Galactosidase beta-1-like (senescence) GLB1L3 −3.0
Eukaryotic translation initiating factor 2B
subunit gamma 3
EIF2B3 −2.6




Elongation factor RNA Pol II, 2 ELL2 −2.0
Telomerase associated protein-1 TEP1 −2.67
Death associated protein kinase 2 DK2 −2.4





Chemokine (C-C motif) ligand 2 CCL2 −3.19
Genes were identified from the gene expression array using Genespring
software and GO analysis to assign functional categories as described in
Methods; additional genes were identified manually from inspection of the
arrays. All values are significant (p < 0.05, n = 3).
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As discussed above, oxygen tensions above 15 mmHg
enhance proliferative and migratory potential of MSCs
while tensions below10 mmHg decrease proliferation
[8-12,17-19]. In agreement with this we found that pro-
liferation of hMSCs was decreased under a pO2 of
4 mmHg and the cultures became stationary after 3 days
(data not shown). Enhanced proliferation under moder-
ate hypoxia has been attributed to down-regulation of
the p21-Ras pathway and increased activity of PI3-
kinase-Akt while increased migration was attributed to
increased expression of c-MET, VEGF, CXCR4 and
CXCR1 (reviewed in [16]). Whereas we also observed
increased expression of c-MET and VEGF-A we found
no change in expression of CXCR receptors, increased
expression of p21-Ras and decreased activity of the
PI3-kinase-Akt pathway (see Tables 2 and 3). PI3-
kinase-Akt is a central regulator of cell growth and sur-
vival. We found that the expression of both IGF-1 and
Figure 5 Keratin induction and reorganization of intermediate-
and micro-filaments under hypoxia. (A)Western blot of Keratin-16
expression in normoxic (N-MSC) and hypoxic (H-MSC) human MSCs.
(B) Keratin immunostaining and (C) F-actin immunostaining of MSCs
cultured for 24 h under normoxia (N-MSC) or hypoxia (H-MSC). Western
blots and immunostaining are described in Methods. All results are
representative of 3 separate experiments; *p < 0.05, n = 3.
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while multiple IGF-1BPs were increased (Tables 2 and 3).
To determine whether these changes were reflected by
parallel changes in pathway activity we measured the
phosphorylation of Akt-Thr308 after culture under nor-
moxia or hypoxia. As shown in Figure 6, phosphor-Akt-
Thr308 levels were significantly lower after hypoxia. This
contrasts with the effects of moderate hypoxia where Akt
phosphorylation is increased [26]. Other down-regulated
transcripts related to growth and survival included senes-
cence marker galactosidase beta-1-like (−3.0) and death
associated kinase-2 (−2.4). There were also decreases of
several interleukins and the cell migration cytokine CCL2,
also known as MCP-1.Glucose metabolism
During hypoxic exposure, cells switch from oxidative
metabolism to anaerobic glycolysis for energy produc-
tion. Glycolysis is less efficient than oxidative phosphor-
ylation and more glucose is required to sustain the same
level of cell function. Glycolytic enzyme and glucose
transporter genes are regulated by HIF-1α and previous
studies have reported their induction by moderate hyp-
oxia in the range of 20–40 mmHg [13,14,17-19]. We
found increased transcript levels of at least 2 key glyco-
lytic pathway genes, PFK and PGK, decrease levels of
PGAM, no change of GAPDH and decreased transcripts
of glucose-6-phosphate dehydrogenase (G6PDH) and
pyruvate dehydrogenase PDH; the latter two enzymes
are involved in the pentose phosphate pathway (PPP)
and acetyl-CoA production respectively. In addition, out
of 7 regulated glucose transporters 4 were induced and 3
repressed by hypoxia. The results indicate mixed re-
sponses of glucose metabolizing genes. Decreased flux
through the PPP is predicted to decrease antioxidant
capacity through lower NADPH production, an effect
consistent with the down-regulation of other anti-
oxidant pathways discussed above.
Hypoxia-related AS events
Exon Microarrays identified 53 genes that were sub-
jected to hypoxia-dependent AS; the arrays also revealed
a correlation between high splice index and genes that
responded the most strongly at the level of gene tran-
scripts. As shown in Figure 7, eight of the most strongly
induced genes and 5 of those that were most strongly re-
pressed also had the highest splicing indices. This suggests
a possible mechanistic link between gene regulation and
control of AS by hypoxia. LEP, IL-11, IGFBP1, TEK, CA9,
LOX4, HCK and EGR2 were each induced by more than
5-fold by hypoxia whereas EFNA3, CORO7, FER1L5,
MYH2 and ACAT1 were each repressed (preferentially
expressed in air) by greater than 4-fold under hypoxia.
Four of the induced genes are HIF-1 targets and EFNA3 a
down-regulated transcript, is an inhibitor of angiogenesis
and target of the HIF-1-regulated microRNA-210 [57].
GO analyses indicated that the predicted functions of
genes with hypoxia-regulated AS included cell adhesion,
migration, apoptosis, angiogenesis and oxidation-reduction
(Table 4). In terms of exon use, 8 of the identified AS events
are described in the human genome annotation (5 C-
terminus, 2 cassette-exon, 1 alt-3′ split site), and 16 involve
constitutive exons. The remainder are novel AS events.
We chose two alternatively spliced genes, ALDH3A2
and NDRG4 for further analysis and qPCR confirmation;
ALDH3A2 transcripts were decreased by hypoxia whereas
NDRG4 were not regulated. ALDH3A2 is a member of
the ALDH superfamily of NAD(P) + −dependent enzymes
that catalyze the oxidation of a wide variety of aliphatic
Figure 6 Western blot and quantification of phosphor-Akt expression in normoxic (N-MSC) and hypoxic (H-MSC) human MSCs (A and B).
Western blot procedures are described in Methods. Akt-P-Thr308 quantification was by NIH image using total Akt as loading control; *p < 0.05, n = 3.
Hu et al. BMC Genomics 2014, 15:303 Page 10 of 18
http://www.biomedcentral.com/1471-2164/15/303and aromatic aldehydes. ALDH3A2 is also known as fatty-
aldehyde dehydrogenase (FALDH) because of its role
in protecting against lipid peroxidation [58]; loss of
ALDH3A2 activity is the cause of Sjogren-Larsson syn-
drome [59]. As shown in Figure 8A, hypoxia/normoxia
dictate the use of AS to generate alternative isoforms
of the ALDH3A2 gene. Exon array analysis revealed
that the AS event occurred in the last exon, while PCR
validation confirmed that the unique exon 10 was not
expressed in hypoxic MSCs. This indicates preferentially
expression of the M2 isoform under hypoxia (Figure 8B).
Previous work has shown that hypoxia can repress the ex-
pression of both constitutive and induced ALDH3 iso-
forms [60] and it is also known that ALDH3A2 gene
expression is positively regulated by PPARα [61]. Our
finding that PPARα expression is also decreased by hyp-
oxia in parallel with ALDH3A2 (Table 3) suggests a pos-
sible mechanism for the transcriptional repression of
ALDH3A2 by hypoxia. Other work has shown that AS of
the ALDH3A2 gene may determine its subcellular
localization with physiological implications for functionFigure 7 Splicing maps of highly regulated genes with high splice indic
TEK, CA9, LOX4, HCK, ERG2) and negative (EFNA3, CORO7, FER1L5, MYH2, ACT
indicate hypoxic/normoxic differential exonic expression levels (n = 3).[62]. Our results are the first to show that hypoxia regu-
lates AS of the FALDH gene.
The N-myc downstream-regulated gene (NDRG) fam-
ily belongs to the alpha/beta hydrolase super family of
genes that regulate survival, growth and differentiation
of host cells. The NDRG4 isoform is preferentially
expressed in brain and heart and its overexpression has
been linked with an aggressive behavior of meningioma
tumors [63]. AS variants of NDRG4 include heart (H)
and two brain (B- and Bvar) isoforms [64]. As shown
in Figure 8C, exon 5 of the NDRG4 gene was subject
to hypoxia-dependent AS according to the exon micro-
array, and this was validated by qPCR. Alternatively
spliced transcripts of the NDRG genes have been de-
scribed although the functional significance is un-
known [64,65].
Tissue-specific regulation of gene expression and AS by
hypoxia
Weigand et al. [35] recently reported results of their
global analyses of hypoxia-regulated AS using humanes. Genes were selected based on highest positive (LEP, IL11, IGFBP1,
A1) fold change of gene expression hypoxia vs. normoxia. Bar graphs











Induction of apoptosis by
intracellular signals
SART1 NM_005146 0.46 Exon11 Squamous cell carcinoma antigen recognized by T cells
Positive regulation of neuron
apoptosis
PTPRF NM_002840 2.56 Exon34 Protein tyrosine phosphatase, receptor type, F
Apoptosis PPP1R13L NM_006663 2.01 Exon13 Protein phosphatase 1, regulatory (inhibitor) subunit 13 like
STEAP3 NM_182915 2.22 Exon6 STEAP family member 3
TNFRSF14 NM_003820 2.39 Exon8 Tumor necrosis factor receptor superfamily, member 14
(herpesvirus entry mediator)
Negative regulation of apoptosis ERCC2 NM_001130867 0.42 Exon8 Excision repair cross-complementing rodent repair deficiency,
complementation group 2
Anti-apoptosis SERPINB2 NM_002575 0.48 Exon8 Serpin peptidase inhibitor, clade B (ovalbumin), member 2
Proliferation-associated
Cell growth ACTA1 NM_001100 0.22 Exon6 Actin, alpha 1, skeletal muscle
NDRG4 NM_001130487 2.62 Exon5 NDRG family member 4
Cell cycle checkpoint ERCC2 NM_001130867 0.42 Exon8 Excision repair cross-complementing rodent repair deficiency,
complementation group 2
Multicellular organism growth ERCC2 NM_001130867 0.42 Exon8 Excision repair cross-complementing rodent repair deficiency,
complementation group 2
Cell proliferation ERCC2 NM_001130867 0.42 Exon8 Excision repair cross-complementing rodent repair deficiency,
complementation group 2
MT3 NM_005954 2.72 Exon3 Metallothionein 3
Cell cycle arrest SART1 NM_005146 0.46 Exon11 Squamous cell carcinoma antigen recognized by T cells
Positive regulation of cell
proliferation
IL11 NM_000641 7.99 Exon5 Interleukin 11
Negative regulation of cell
proliferation
PTPRF NM_002840 2.56 Exon34 Protein tyrosine phosphatase, receptor type, F
Migration-associated
Axon guidance SLIT3 NM_003062 0.44 Exon1 Slit homolog 3 (Drosophila)
SEMA5A NM_003966 2.90 Exon23 Sema domain, seven thrombospondin repeats
(type 1 and type 1-like), transmembrane domain (TM)
and short cytoplasmic domain, (semaphorin) 5A
Motor axon guidance EGR2 NM_000399 5.08 Exon2 Early growth response 2
Cell migration PVR NM_001135770 0.49 Exon3 Poliovirus receptor
Positive regulation of cell
migration
LAMB1 NM_002291 0.46 Exon9 Laminin, beta 1




RUNX1 NM_001122607 0.40 Exon1 Runt-related transcription factor 1
Wound healing SERPINB2 NM_002575 0.48 Exon8 Serpin peptidase inhibitor, clade B (ovalbumin), member 2
Differentially spliced genes in human MSCs under hypoxia, were subjected to GO analysis as described in Methods.
Hu et al. BMC Genomics 2014, 15:303 Page 11 of 18
http://www.biomedcentral.com/1471-2164/15/303umbilical vein endothelial cells (HUVECs). Because
our results as well as those of others suggest that many
of the effects of hypoxia are tissue-specific we com-
pared our gene expression and AS array data with that
of Weigand et al. These results are shown in Supple-
ment Figures 2, 3 and 4. Out of 446 and 113 genes reg-
ulated >2.5-fold by hypoxia in hMSCs and HUVECsrespectively only 9 were commonly regulated including
ANGPTL4, VEGFA, STC, SLC2A3, PGF, EGLN3, ADM,
BHLHE40 and NQO1 (Additional file 2: Figure S2). Out
of 541 and 239 gene isoforms created by hypoxia-
regulated AS in hMSCs and HUVECs respectively, only
17 isoforms were common (Additional file 3: Figure S3).
As shown in Additional file 4: Figure S4 comparing all
Figure 8 Oxygen-dependent differential splicing of the ALDH3A2 and NDRG4 genes. (A) Expression of splice isoforms confirmed by RT-PCR of
genes with prior evidence of AS. (B) Annotation of each alternative isoform (M2 and M1, top graphic), exon structure (middle graphic) and expression
profiles (bottom graphic) for ALDH3A2. Light blue boxes indicate down-regulation for hypoxic (H) versus normoxic (N) MSCs; gray boxes indicate no
significant change; white boxes indicate no probe detection above expression threshold. The green exon (exon10) indicates the unique exon of
isoform M1. Exon expression values (log2) are displayed for both H-MSC (black data points) and N-MSC (red data points), ranked in order of genomic
position on the x-axis. The various isoforms can be validated in the PCR result although there is no probe annotated to the isoform-specific exon.
(C) Exon structure (top graphic) modified domain of AS (middle graphic) and expression profiles (bottom graphic) for NDRG4. Light red boxes indicate
up-regulation for hypoxic (H) versus normoxic MSCs (N) MSCs; gray boxes indicate no significant change; white boxes indicate no probe detection
above expression threshold. A Modified or disrupted conserved domain of differentially expressed exon is from the CDD database (NCBI). Exon expression
values (log2) are displayed for both H-MSC (black data points) and N-MSC (red data points), ranked in order of genomic position on the x-axis.
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http://www.biomedcentral.com/1471-2164/15/303of the genes in hMSCs and HUVECs regulated by hyp-
oxia at the levels of gene expression and AS only 3
genes were common. These included Egln3, a prolyl
hydroxylase involved in HIF-1 proteolytic targeting,
stanniocalcin-1 (STC) a pro-angiogenic anti-apoptosis
gene product [66,67] (both up-regulated) and NAD(P)Quinone oxidoreductase 1 (NQO1) a Phase II redox
detoxification enzyme [68], (down-regulated). It should
be noted that Weigand et al. exposed HUVECs to 1%
oxygen for 48 h compared with our 0.5% for 24 h there-
fore the differences may be due in part to different oxy-
gen tension as well as cell type.
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Our studies suggest that severity of hypoxia within a
range of 4–10 mmHg is a critical determinant of global
gene expression that has important implications for the
biology and function of human MSCs. Transcriptional
profiling revealed altered patterns of gene expression
particularly involving glucose metabolism, insulin/IGF-1
signaling, intermediate filaments, extracellular matrix,
anti-oxidant enzymes, and differentiation-markers. The
results are consistent with the quiescent, immobile state
conferred by severe hypoxia along with reduced oxida-
tive stress and a switch in favor of osteogenic, angiogenic
and perhaps hematopoietic programs over those of adi-
pogenesis and myogenesis. The gene expression profiles
are distinct in many respects from those described previ-
ously for MSCs subjected to more moderate hypoxia
that mediates enhanced proliferation [9,10,17-19].
Salient features of the present study that define the
role of severe hypoxia and distinguish it from moderate
hypoxia include the following: [1] Mixed responses of
genes involved in glucose metabolism including the pen-
tose phosphate and glycolysis pathways, and moderately
induced or decreased levels of glucose transporter gene
transcripts. Although glycolytic flux increased acutely
under hypoxia, a lower than a maximal induction of all
genes may be physiologically beneficial in the long term
for a closed environment such as the endosteum where
high glycolytic activity would generate localized acidosis
and cell death. An analogous condition may be repre-
sented in anoxic turtles where the PGAM gene is also
repressed and may contribute to the hypometabolic state
that is necessary for the turtle to survive extended an-
oxia [69]. Notable also is the weak induction of Bnip3, a
programmed cell death protein normally strongly in-
duced by hypoxia through HIF-1α and co-regulated by
hypoxia and acidosis [70]. Also noteworthy is the strong
induction of carbonic anhydrase (CA9) suggesting a pre-
emptive adaptation to acidosis [2]. IGF-1 and PI3-kinase
transcripts were decreased while IGFBP-1, −3 and −5
transcripts were increased, and this was associated with
depressed phosphorylation of Akt-Thr308 (Figure 6).
The IGF-PI3-kinase pathway regulates cell growth and
survival through key targets including mTOR and p70-
S6-kinase, and its depressed activity by severe hypoxia is
consistent with reduced growth and metabolism. PI3-
kinase signaling and phosphor-Akt were reported to be
activated in MSCs by moderate hypoxia [26] therefore the
reduced activity by severe hypoxia again distinguishes the
two conditions [6]. Acidic keratins were markedly in-
creased by hypoxia and this correlated with a more polar
organization of intermediate filaments and cell elongation.
The acidic keratin genes are clustered on chromosome
17q and the coordinately increase levels of multiple
transcripts suggests a common regulatory mechanism.Regulation of keratin expression by the HIF pathway has
not been reported. It is also noteworthy that whereas
acidic keratin transcripts were all induced, 3 basic keratin
gene transcripts decreased. Cytosolic keratins are markers
of epithelium and the strong inductions are reminiscent of
mesenchymal to epithelial transition (MET) that is associ-
ated with reduced rates of growth and migration [43-45].
Such a partial transition is again consistent with the
quiescent immobile state predicted by the severely hyp-
oxic environment of the endosteum. Changes in expres-
sion of multiple collagen and actin genes provides
additional evidence for dynamic changes in cytoskel-
eton and extracellular matrix that contribute to cell
growth and mobility [3]. Reduced expression of antioxi-
dant pathway genes in particular NAD(P)H quinone-1
and aldo-keto reductase family members is consistent
with lower oxidative stress created by severe hypoxia
and may be associated with lower electron leakage and
free radical production by mitochondria. Lower ROS
and oxidative stress may also contribute to reduced
proliferation [4]. Enhanced expression of osteogenic
and angiogenic marker genes and depressed expression
of adipogenic and myogenic markers is consistent with
some but not all previous studies. Mayer et al. [48]
and Hung et al. [10] found that osteogenesis was in-
duced in MSCs by an oxygen tension of 10 mmHg.
Hung et al. also reported that adipogenesis was re-
duced by 10 mmHg whereas Fink et al. [46] and Kato
et al. [16] reported the opposite effect with increased
adipogenesis under the same pO2. The differences
may be due to incubation conditions and whether the
cell are exposed to reoxygenation during treatments;
Hung et al. [12] reported that the effects of hypoxia
on proliferation and differentiation were fully reversed
by reoxygenation.
The induction of numerous markers of angiogenesis is
consistent with many previous reports describing angio-
genic activation by hypoxia. The selective decrease of
multiple myogenic gene markers by severe hypoxia is a
novel observation of this study.
This is the second report to describe global changes in
the alternative splicing of genes mediated by hypoxia
and the first to describe such an effect in stem cells.
There was only a small amount of overlap of hypoxia-
regulated alternatively spliced genes in HUVECs versus
MSCs with only 17 commonly regulated exons. It is
noteworthy that multiple genes that were highly regu-
lated at the transcript level in hMSCs were also subject
to differential exon inclusion suggesting possible com-
mon regulatory factors in both pathways. Regulators of
AS include specific RNA binding proteins and transcrip-
tion factors (reviewed in [32]). It is known that transcrip-
tion factor binding can influence AS perhaps by
influencing the concentration of direct AS regulators
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of RNA polymerase II elongation, leading indirectly to
AS. Extracellular signals can also modify AS events by
changing the activity of regulators for example, hnRNP-
A1 (heterogeneous nuclear ribonucleoprotein A1) an
RNA binding protein involved in nuclear pre-RNA pro-
cessing that inhibits the inclusion of multiple alternative
exons becomes phosphorylated upon osmotic shock
resulting in cytoplasmic accumulation with consequent
effects on AS [71]. HIF-1 was shown to regulate differ-
ential splicing of the LDH gene in shrimps [72], as well
as AS of the hTERT gene that regulates telomerase ac-
tivity in mammalian cells [73]. Of the most strongly
and dually (transcripts and AS) regulated genes LEP,
IGFBP1, CA9 and LOXL4 are all HIF-1α regulated.
Therefore HIF-1α may contribute to the AS of
dependent genes providing dual and coordinated regu-
lation of transcription and AS by hypoxia. It is difficult
to assess the physiological significance of most of the
AS responding genes without information on the func-
tional consequences, however it was possible to group
the genes into functional categories of cell survival,
proliferation, mobility and differentiation (Table 4).Conclusion
We report on molecular genetic and phenotypic changes
conferred on hMSC by severe hypoxia. The gene expres-
sion changes are largely distinct from those reported previ-
ously for more moderate hypoxia that support enhanced
proliferation, and the results are consistent with a quies-
cent, immobile phenotype with reduced metabolic activity
and lower oxidative stress. Hypoxia-mediated AS may con-
tribute importantly to gene regulation and protein function
during adaptation to a severely hypoxic environment such
as that imposed by the bone marrow endosteum.Methods
Isolation, culture and characterization of human MSC
Normal human bone marrow aspirates were obtained
with written consent from healthy donors in accordance
with the Declaration of Helsinki and with the approval
of the Human subjects Ethics Committee of Second
Affiliated Hospital of Zhejiang University. MSCs from
3 such donors were cultured as described previously
[10,12,19,74]. Cell surface markers were profiled using
a BD FACS CantoTM II Flow Cytometry System after
3–5 passages as described previously [75] with the fol-
lowing human specific monoclonal antibodies: CD29-
phycoerythrin (PE) (eBioscience, San Diego, CA, USA),
CD34-PE (MACS, Miltenyi Biotec, Auburn, CA, USA) and
CD166-PE (BD Biosciences Pharmingen, San Diego, CA,
USA), respectively.Hypoxia
MSCs were plated at 1 × 105 cells/cm2 in complete cul-
ture medium and incubated under hypoxia (0.5% O2, 5%
CO2) or normoxia (21% O2, 5% CO2) for 24 hours using
a ProOX Model C21 system (BioSpherix, Redfield, NY,
USA).
RNA extraction
Total RNA from normoxic and hypoxic MSCs (3 inde-
pendent donor samples each) was extracted using a Kit
from Biochain, (Hayward, CA, USA), according to the
manufacturer’s instructions. The RNA quality was assessed
by formaldehyde agarose gel electrophoresis and quantified
using a spectrophotometer (Nanodrop, Wilmington, DE,
USA).
RNA amplification and labeling
Gene expression microarray: RNA was amplified, reverse
transcribed and labeled as described previously [36].
Briefly, 1 μg of total RNA was amplified using a Message
AmpTM II RNA Amplification kit (Life Technologies,
Austin, TX, USA). The RNA was reverse transcribed in
the presence of cy3-dCTP or cy5-dCTP using Klenow
enzyme. For exon microarray, RNA from 3 separate rep-
licate samples of normoxic or hypoxia MSCs was ampli-
fied using a Low Input Quick Amp WT Labeling Kit
from Agilent.
Array hybridization and data acquisition
Hybridization, scanning and washing were performed on
Agilent’s Microarray Platform according to standard pro-
tocols. Raw data were acquired using an Agilent DNA
microarray scanner and Agilent feature extraction soft-
ware. All data is MIAME compliant and raw files from
the 6 arrays (n = 3 per group) are deposited in the GEO
database at NCBI (GEO accession # GSE55875). In
addition, we downloaded from the NCBI GEO database
the 6 raw data files (n = 3 per group) from the AS study
by Weigand et al. [35].
Gene and AS analyses
All raw text files (from hMSC Agilent arrays) and CEL
files (from HUVEC Affymetrix arrays) were imported
into GeneSpring GX 11 software (Silicon Genetics,
Redwood City, CA) for either global gene analysis or al-
ternative splicing. A total of four analytical experiments
were performed with 3 replicate arrays for each condi-
tion. Normalized expression values were calculated by
the Robust Multi-array Average (RMA) method. The
resultant signal information was analyzed using one-
way analysis of variance (ANOVA) (p < 0.05), assuming
normality and equal variances. Multiple Testing Correc-
tion (MTC) of p-values by Benjamini Hochberg screened
out >90% of regulated genes (33/446) including many of
Hu et al. BMC Genomics 2014, 15:303 Page 15 of 18
http://www.biomedcentral.com/1471-2164/15/303the known HIF-1α-regulated genes such as metallothio-
nein (MT3), carbonic anhydrase XII (CA12; 4.6-fold),
(VEGFA; 4.6-fold) and placental growth factor, (PGF;
3.28-fold) (Table 1), as well as many of the gene tran-
scripts that were subsequently confirmed by QPCR
including phosphoglycerate kinase (PGK; 7.1-fold), phos-
phofructokinase (PFK; 3.2-fold), RAS p21 protein activator
(RASA1; 2.9-fold) and Immediate Early Response 3 (IER3;
2.5-fold). MTC is known to screen out false positives as
well as many true positives, therefore as in our previous
micro-array studies [74,76] it was not employed here. The
GeneSpring Cross Gene Error model was applied; this
model determines the likelihood of observing a specific
fold change to the likelihood of observing a fold measure-
ment by the 50.0th percentile of all measurements in the
sample. The average value of expression level for each
gene across the samples is set to 1.0 and the resulting nor-
malized signal value plotted for each sample. Lists of
differentially expressed genes from different experiments
were compared within GeneSpring and displayed as
Venn diagrams to show overlapping and non-overlapping
genes. Heatmaps and graphs were also generated within
GeneSpring.
Conserved domain function annotation of AS exons
To identify protein domains of genes modified by AS, a
conserved domain database (CCD) from NCBI web ser-
vices was used. By default, domain predictions are de-
rived by comparing two protein isoform sequences: one
that aligns to the alternative exon and another in which
the exon is absent from the corresponding mRNA se-
quences (competitive isoform).
Validation of the differentially expressed genes
Differentially expressed genes-of-interest were selected
based on function and confirmed using quantitative
real-time (RT-q) PCR. 2 μg of total RNA respectively
from normoxic and hypoxic MSCs was reverse tran-
scribed with oligo (dT)18 using M-MLV reverse tran-
scriptase (TAKARA, Japan) in a volume of 40 μL.
Following reverse transcription, 1 μl of this cDNA mix-
ture was employed for a qPCR program of 40 cycles (10 s
at 95°C/32 s at 60°C) with SYBR®Premix Ex TaqTM. Data
were generated using Perfect Real Time (TAKARA, Japan)
and Real-Time PCR (Applied Biosystems, Foster City, CA,
USA). Data were analyzed by the 2-ΔΔCt method and re-
sults are shown as fold change relative to control.
Confirmation of alternative exon expression
24 alternative exon sequences were selected for confirm-
ation by RT-qPCR. The sequences of the AS exon and its
neighboring exons were acquired from the Human Gen-
ome UCSC Genome Database. If AS of the last exon of a
gene was indicated, the last two-exon sequences of thisgene were accessed. Constitutive exon-specific primers
were designed and after reverse transcription, qPCR prod-
ucts were separated in 1% agarose gels supplemented with
ethidium bromide, and visualized by UV.
Enzyme-linked immunosorbent assay (ELISA)
Leptin and VEGF concentrations in culture medium of
normoxic and hypoxic MSCs were measured by ELISA
(R&D System, Minneapolis, MN, USA), according to the
manufacturer’s instructions. Assays were conducted on a
SoftMax Pro® multiplate reader (Molecular Devices, Inc.,
Downingtown, PA, USA).
Western blot
Our western blot procedures are described in detail else-
where [77,78]. Briefly, equal amounts of protein were
separated by 10-15% SDS polyacrylamide gel electro-
phoresis and electro-transferred onto an Immobilon-P
Transfer Membrane (Millipore, Billerica, MA, USA).
Membranes were blocked with 5% BSA in TBS-T and in-
cubated with VEGF (Santa Cruz Biotechnology, Santa
Cruz, CA, USA), leptin, α-tubulin, or Akt (R&D System),
antibodies overnight at 4°C. Horseradish peroxide–con-
jugated secondary antibodies were hybridized by stand-
ard procedures. β-actin was used as loading control.
F-actin and keratin intermediate filament staining
Normoxic and hypoxic MSCs were examined for actin
filaments organization using Alexa Fluor 555 phalloidin
(Invitrogen). Briefly, MSCs were fixed in 4% formalde-
hyde for 10 min, permeabilized with 0.1% Triton X-100
for 5 min, and blocked with PBS containing 1% BSA for
25 min. Cells were stained with diluted phalloidin in
PBS for 20 min at room temperature and viewed under
a fluorescence microscope.
Statistical analysis
One-way ANOVA was used to compare experimental
groups. Data are expressed as mean ± standard deviation
(SD), and a p value < 0.05 was considered as statistically
significant.
Additional files
Additional file 1: Figure S1. Differential MSC gene expression. Heatmap
of the top differentially expressed genes by at least 2.0-fold (p < .01) in
hMSCs under hypoxia relative to normoxia.
Additional file 2: Figure S2. Venn diagram and heatmap of
differentially expressed genes that overlap in hMSCs and HUVECs under
hypoxia. (A). Differentially expressed genes determined by our analyses
of HUVECs and human MSCs under hypoxia were compared to find
common differentially expressed transcripts. A 2.0 fold change and
p < 0.01 significance cut-offs were used. (B). Selected genes, including
VEGF-A, from the 9 transcripts overlapping in HUVEC and hMSCs, are
shown by heatmap displaying expression levels in normoxic and
hypoxic MSCs. Color bar shown is Log2.
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http://www.biomedcentral.com/1471-2164/15/303Additional file 3: Figure S3. Venn diagram and graphs of differentially
expressed isoforms overlapping in hMSCs and HUVECs under hypoxia. (A).
Differentially expressed isoforms determined by our analysis of HUVECs and
human MSCs under hypoxia were compared to find common differentially
expressed exons. A 1.0 splicing index and p < 0.01 significance cutoffs were
used. (B). Exonic expression of 17 isoforms overlapping in HUVECs and
hMSCs are shown in the graphs displaying the hypoxic vs. normoxic exonic
expression levels.
Additional file 4: Figure S4. Venn Diagrams and heatmap of
differentially expressed genes overlapping genes in hMSCs versus HUVECs.
Differentially expressed genes and isoforms determined by our analysis of
HUVECs and human MSCs under hypoxia were compared to find common
or unique differentially expressed genes and isoforms. A 1.0 splicing index,
2.0 fold change, and p < 0.01 significance cut-offs were used.
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